{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:52:33Z","timestamp":1781517153742,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Oligodendrogliomas (ODGs) are IDH-mutated gliomas with 1p\/19q co-deletion, typically associated with better outcomes than astrocytomas. Symptomatic leptomeningeal dissemination (LMD) is exceptionally rare, and predictors of its occurrence remain poorly defined. This scoping review aimed to synthesize the available literature on LMD in ODG and identify potential clinical, radiological, surgical, and histo-molecular risk markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed\/MEDLINE and Embase were systematically searched for studies reporting cases of ODG with LMD. Extracted data included demographics, tumor features, imaging, treatment, molecular markers, and outcomes. Findings were descriptively summarized. An illustrative institutional case was also reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1719 records screened, 15 studies met inclusion, comprising 48 patients. The mean age at LMD diagnosis was 43.1 years, with male predominance (M: F\u00a0=\u00a02.4:1). Most patients (39 of 41 patients [85.7%]) had WHO grade 3 ODG at LMD diagnosis. When explicitly stated, LMD was associated with surgical entry into the ventricles (2 of 4 patients [50%]), a Ki-67 index of \u226515% (6 of 7 patients [85.7%]), and contrast enhancement on MRI (4 of 8 patients [75%]). The median time from ODG diagnosis to LMD was 35 months (range 0\u2013274 months). Median survival after LMD was 9.9 months (range 1.8-67.7). Our case reflected these patterns, with 14 years of stable disease followed by rapid decline after LMD onset. Treatments included chemotherapy (23 of 39 patients [58.9%]), radiotherapy (14 of 39 patients [35.9%]), and surgery (12 of 40 patients [30%]), with uncertain benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>LMD in ODG is rare but associated with poor prognosis. Features such as grade 3 histology, ventricular involvement, surgical entry into ventricles, contrast enhancement, and high Ki-67 may indicate potential risk markers. These findings support long-term whole-neuroaxis MRI surveillance in selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1757720","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:57Z","timestamp":1781513757000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Is leptomeningeal dissemination in oligodendroglioma predictable? Evidence from a scoping review"],"prefix":"10.3389","volume":"16","author":[{"given":"Hanna Veronika","family":"Salvotti","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Brigo","sequence":"additional","affiliation":[{"name":"Research and Teaching Service (IRTS), Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Cipriano","family":"Cecchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Costazza","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Pirillo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Zavatto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Erdini","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Berti","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)","place":["Bolzano-Bozen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051133","article-title":"Oligodendroglioma: advances in molecular mechanisms and immunotherapeutic strategies","volume":"13","author":"Zhao","year":"2025","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150857","article-title":"Imaging of oligodendroglioma","volume":"89","author":"Smits","year":"2016","journal-title":"Br J Radiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-973","article-title":"An overview of leptomeningeal disease","volume":"10","author":"Nguyen","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007529","article-title":"Leptomeningeal metastases in glioma: the Memorial Sloan Kettering Cancer Center experience","volume":"92","author":"Andersen","year":"2019","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0258","article-title":"Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges","volume":"25","author":"Birzu","year":"2020","journal-title":"Oncologist"},{"key":"B8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11060-014-1592-1","article-title":"Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution","volume":"120","author":"Mandel","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3171\/2018.11.peds18506","article-title":"Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth","volume":"23","author":"Fults","year":"2019","journal-title":"J Neurosurg Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2014.00220","article-title":"Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients","volume":"5","author":"Dardis","year":"2014","journal-title":"Front Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3171\/2022.12.jns221490","article-title":"Identification of risk factors associated with leptomeningeal disease after resection of brain metastases","volume":"139","author":"Morshed","year":"2023","journal-title":"J Neurosurg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-015-2344-5","article-title":"Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome","volume":"157","author":"Noh","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2024-0105","article-title":"Frequency and prognostic impact of CDKN2A\/B alteration in oligodendrogliomas: systematic review and meta-analysis","volume":"64","author":"Nakasu","year":"2024","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7326\/m18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"B15","volume-title":"Joanna briggs institute reviewers\u2019 Manual","year":"2015"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11060-022-04233-y","article-title":"Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities","volume":"162","author":"Park","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/2022.9.jns221659","article-title":"Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging","volume":"139","author":"Park","year":"2022","journal-title":"J Neurosurg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-020-00211-4","article-title":"Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict Malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine","volume":"11","author":"Im","year":"2020","journal-title":"EPMA J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3769\/radioisotopes.61.209","article-title":"Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1(R132H) mutation-negative glioblastoma","volume":"133","author":"Kondo","year":"2017","journal-title":"J Neuro-Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45526","article-title":"Naturopathic treatment of grade III oligodendroglioma with progression to grade IV isocitrate dehydrogenase (IDH)-mutant astrocytoma and the development of spinal gliomatosis","volume":"15","author":"Terrani","year":"2023","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2022.10.1347","article-title":"Symptomatic spinal seeding metastasis of a low-grade oligodendroglioma","volume":"32","author":"Keskin","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155315","article-title":"Addition of anti-angiogenetic therapy with bevacizumab to chemo- and radiotherapy for leptomeningeal metastases in primary brain tumors","volume":"11","author":"Burger","year":"2016","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.360919","article-title":"Symptomatic spinal intramedullary metastasis (SIM) in a postoperative case of low-grade intracranial oligodendroglioma after nine years","volume":"70","author":"Attri","year":"2022","journal-title":"Neurol India"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26708","article-title":"Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: case report and review of literature","volume":"64","author":"Sorge","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51035","article-title":"CyberKnife radiosurgery for extracranial metastases of oligodendroglioma: a clinical case report","volume":"15","author":"Shaghaghian","year":"2023","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12765","article-title":"69-year-old male with an intradural, extramedullary mass at T12-L1","volume":"29","author":"Velz","year":"2019","journal-title":"Brain Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.01.017","article-title":"Spinal leptomeningeal oligodendrogliomatosis after resection of cerebral anaplastic oligodendoglioma with 1p19q co-deletion - a case report","volume":"73","author":"Felipe Andres","year":"2020","journal-title":"J Clin Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21037\/jss.2017.06.14","article-title":"Spinal metastases of two different grade oligodendrogliomas: a case report and review of literature","volume":"3","author":"Maiguel Carrizosa","year":"2017","journal-title":"J Spine Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1086591","article-title":"Case report: spinal drop metastasis of IDH-mutant, 1p\/19q-codeleted oligodendroglioma","volume":"13","author":"Karaman","year":"2022","journal-title":"Front Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0551-3","article-title":"Leptomeningeal disease in oligodendroglial tumors: a population-based study","volume":"104","author":"Rold\u00e1n","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100008647","article-title":"Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis","volume":"35","author":"Rold\u00e1n","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/370901","article-title":"Acute hydrocephalus due to secondary leptomeningeal dissemination of an anaplastic oligodendroglioma","volume":"2009","author":"Stark","year":"2009","journal-title":"Case Rep Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03864-x","article-title":"Leptomeningeal disease in glioblastoma: endgame or opportunity","volume":"155","author":"Akmal","year":"2021","journal-title":"J Neuro-Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.22541\/au.172829535.51286862\/v1","article-title":"Diagnosis of leptomeningeal disease in diffuse midline gliomas by detection of H3F3A K27M mutation in circulating tumor DNA of cerebrospinal fluid","volume":"72","author":"Shibuma","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.722396","article-title":"Oligodendroglioma: a review of management and pathways","volume":"14","author":"Bou Zerdan","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"van den Bent","year":"2013","journal-title":"J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/nop\/npy044","article-title":"Neuro-oncology clinical debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma","volume":"6","author":"Ruff","year":"2019","journal-title":"Neuro-Oncol Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-023-01265-3","article-title":"Therapies for IDH-mutant gliomas","volume":"23","author":"Alshiekh Nasany","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1212\/wnl.0000000000211647","article-title":"Leptomeningeal dissemination after GammaTile and LITT in high grade astrocytoma patients (P1-6.004)","volume":"104","author":"Mian","year":"2025","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04933-7","article-title":"Leptomeningeal dissemination in H3 K27M-mutant diffuse midline gliomas: clinical characteristics, risk factors, and prognostic insights","volume":"172","author":"Zhong","year":"2025","journal-title":"J Neuro-Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1347877","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballest\u00edn","year":"2024","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2024.100356","article-title":"Proposed novel classification of circumscribed lower-grade gliomas (cLGG) vs. infiltrating lower-grade gliomas (iLGG): correlations of radiological features and clinical outcomes","volume":"23","author":"Khan","year":"2024","journal-title":"World Neurosurgery: X"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04929-3","article-title":"Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas","volume":"172","author":"Zhao","year":"2025","journal-title":"J Neuro-Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-024-03430-y","article-title":"Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade","volume":"66","author":"Lee","year":"2024","journal-title":"Neuroradiology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/srep17758","article-title":"Surgical ventricular entry is a key risk factor for leptomeningeal metastasis of high grade gliomas","volume":"5","author":"Roelz","year":"2015","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.08.004","article-title":"Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control","volume":"22","author":"Yuan","year":"2013","journal-title":"Seizure"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12788","article-title":"Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p\/19q-codeleted: a multicenter study from the French POLA network","volume":"30","author":"Pouget","year":"2020","journal-title":"Brain Pathol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.13.5319","article-title":"Prognostic factors in oligodendrogliomas: a clinical study of twenty-five consecutive patients","volume":"16","author":"Atalay","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae221","article-title":"Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p\/19q co-deleted: lessons from the French POLA cohort","volume":"27","author":"Figarella-Branger","year":"2025","journal-title":"Neuro Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3171\/2015.10.jns15583","article-title":"Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data","volume":"125","author":"Zetterling","year":"2016","journal-title":"J Neurosurg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12162","DOI":"10.21203\/rs.3.rs-123195\/v1","article-title":"Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology","volume":"11","author":"Pekmezci","year":"2021","journal-title":"Sci Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1757720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:58Z","timestamp":1781513758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1757720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":52,"alternative-id":["10.3389\/fonc.2026.1757720"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1757720","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1757720"}}